162 related articles for article (PubMed ID: 28586376)
1. Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
Han EC; Ryoo SB; Park JW; Yi JW; Oh HK; Choe EK; Ha HK; Park BK; Moon SH; Jeong SY; Park KJ
PLoS One; 2017; 12(6):e0178920. PubMed ID: 28586376
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the postoperative morbidity and survival of patients with liver cirrhosis following colorectal cancer surgery.
Lee JH; Yu CS; Lee JL; Kim CW; Yoon YS; Park IJ; Lim SB; Kim JC
Int J Colorectal Dis; 2017 Apr; 32(4):521-530. PubMed ID: 27987016
[TBL] [Abstract][Full Text] [Related]
3. The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer.
Kondo T; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kitagawa Y
Br J Cancer; 2016 Jun; 115(1):34-9. PubMed ID: 27280634
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
[TBL] [Abstract][Full Text] [Related]
5. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
[TBL] [Abstract][Full Text] [Related]
6. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
7. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
9. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
10. Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis.
Nishikawa H; Kita R; Kimura T; Endo M; Ohara Y; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
Int J Oncol; 2015; 46(6):2371-9. PubMed ID: 25891119
[TBL] [Abstract][Full Text] [Related]
11. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
12. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
Kim KH; Yang SS; Yoon YS; Lim SB; Yu CS; Kim JC
Colorectal Dis; 2011 Aug; 13(8):e220-6. PubMed ID: 21689314
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
Zeman M; Maciejewski A; Półtorak S; Kryj M
Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
[TBL] [Abstract][Full Text] [Related]
14. Application of propensity score model to examine the prognostic significance of lymph node number as a care quality indicator.
Chang YJ; Chen LJ; Chang YJ; Chung KP; Lai MS
Surg Oncol; 2012 Jun; 21(2):e75-85. PubMed ID: 22221938
[TBL] [Abstract][Full Text] [Related]
15. Liver metastases from colorectal cancer: present surgical approach.
Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
17. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.
Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
19. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
[TBL] [Abstract][Full Text] [Related]
20. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.
Lee BC; Lee HG; Park IJ; Kim SY; Kim KH; Lee JH; Kim CW; Lee JL; Yoon YS; Lim SB; Yu CS; Kim JC
Medicine (Baltimore); 2016 Sep; 95(39):e4999. PubMed ID: 27684857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
